Acthar Gel can start working within days for acute conditions like MS relapses, but takes weeks to months for chronic conditions like nephrotic syndrome or rheumatoid arthritis. The timeline depends almost entirely on what you’re being treated for, because this medication is used across a surprisingly wide range of conditions, each with its own expected response window.
How Acthar Gel Works Differently Than Steroids
Acthar Gel is not a steroid itself. It’s a mixture of compounds that activate a family of receptors throughout the body called melanocortin receptors. One result is that your adrenal glands ramp up cortisol production, which suppresses inflammation. But Acthar Gel also appears to calm the immune system through pathways that are separate from cortisol, directly reducing inflammatory signaling in immune cells. This dual action helps explain why it sometimes works for patients who haven’t responded well to standard steroid treatments, and why the timeline for improvement varies by condition.
MS Relapses: Days to 2 Weeks
For acute multiple sclerosis flares, Acthar Gel works relatively fast. The standard course is daily injections of 80 to 120 units for two to three weeks. In clinical practice, patients have reported improvement in symptoms like blurred vision and difficulty walking within about a week of completing a course. Early controlled studies showed faster recovery from MS exacerbations compared to placebo, and results comparable to intravenous steroids.
A typical treatment course for an MS relapse is short, often just 5 to 14 consecutive days of daily injections. If you’re being treated for a flare, you can reasonably expect to start noticing improvement during or shortly after completing the course. The goal here isn’t long-term disease control but stabilizing a sudden worsening episode.
Infantile Spasms: About 2 Weeks
For infantile spasms, Acthar Gel follows a well-defined protocol. The recommended regimen is a daily dose of 150 units per square meter of body surface area, divided into two daily injections, for two weeks. The treatment is then gradually tapered over an additional two weeks to prevent adrenal problems from stopping abruptly.
Clinical response is typically evaluated at the two-week mark with a video EEG to confirm whether spasms have stopped and whether the abnormal brain wave pattern (called hypsarrhythmia) has resolved. In head-to-head trials, a two-week course of Acthar Gel was more effective than prednisone at suppressing both the spasms and the abnormal EEG pattern. Among infants who don’t respond to initial treatment with steroids, about 40% still respond after switching to a two-week course of Acthar Gel.
Rheumatoid Arthritis: Weeks to Months
Rheumatoid arthritis requires a longer commitment before you can judge whether Acthar Gel is helping. Clinical trials have used regimens of 80 units injected twice weekly for 12 weeks or longer. This isn’t a quick-fix treatment for RA. The usual prescribed dose ranges from 40 to 80 units given every one to three days, and your prescriber will adjust the frequency based on how you respond.
Because RA is a chronic condition with fluctuating symptoms, it can take the full 12-week treatment window to see meaningful joint improvement. If you’ve been on Acthar Gel for RA for several weeks without noticing any change, that doesn’t necessarily mean it’s failing. The clinical evidence is built around evaluation periods of at least 12 weeks.
Nephrotic Syndrome: 3 to 6 Months
Kidney conditions involving excess protein in the urine require the most patience. In studies of patients with nephrotic syndrome, treatment with 80 units of Acthar Gel twice weekly for six months produced a 61% reduction in protein loss in the urine, with some patients achieving complete remission and others partial remission. For one subtype of kidney disease (focal segmental glomerulosclerosis), patients treated for at least 24 weeks saw a nearly 58% reduction in proteinuria.
Notably, dosing matters here more than in other conditions. Patients who received only 80 units once weekly did not see significant improvement, suggesting there’s a minimum threshold below which the medication simply doesn’t produce meaningful kidney results. Overall response rates across different forms of nephrotic syndrome reached about 78.5% after six months of follow-up, but those results require sticking with the treatment for the full duration.
What Affects Your Personal Timeline
Several factors influence how quickly you’ll notice a difference. The severity of your condition at the start of treatment plays a role, as does how your body responds to the melanocortin pathway activation. Dosing frequency and amount are individualized, and the FDA labeling for most conditions explicitly states that your prescriber should adjust the regimen based on your initial response.
The nature of the condition matters most. Acute inflammatory events like MS relapses involve calming a flare that’s already underway, so the drug can produce noticeable results in days to weeks. Chronic autoimmune conditions like RA or nephrotic syndrome involve gradually shifting the immune system’s behavior over time, which is inherently slower. If you’re being treated for a chronic condition, a realistic minimum evaluation period is 12 weeks for joint disease and 24 weeks for kidney disease before drawing conclusions about whether it’s working.
Because Acthar Gel stimulates your adrenal glands, stopping it abruptly after more than a short course can cause problems. Treatment plans typically include a tapering period. For infantile spasms, for example, the two-week treatment phase is followed by a two-week taper. Your prescriber will build this into your timeline, so the total duration of injections will be longer than just the active treatment phase.